CD&R and McKesson are buying Option Care Health
OPCH's Quality Score rose 1 point on Tue, Nov 10, to 13. Its 6-month gain rose to 62%, past 60%.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 12% over three years while the S&P 500 rose 80%; up 12% in the past year.
The other side, how the business stands, the timeline, and its peers, for Pro members.
| Outperforming | Up 62% in 6 months vs the S&P's +2% |
| Latest filing | 8-K, Nov 4 |
CD&R And McKesson To Acquire Option Care Health
OPCH closed +32.6% that day on 28.9x normal volume.
Tue Dec 15: Special Shareholder MeetingDate confirmed.
After its last 4 reports it closed -6.1% on average, higher 1 of 4 times.
Above Averagefor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
Net income over four quarters: OPCH $215M, BTSG $410M, CHE $282M, AVAH $275M.
Expected to report Tue Feb 23, before the open (in 105 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $1.5B, 4% more than a year ago; a profit of $0.38 a share, from $0.32.
OPCH's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
Sales grew 13% a year over 5 years, fiscal 2020 to 2025.
Its share count fell 2% a year over 5 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 4, 2026 | +0.1% | -0.4% | -0.4% |
| Jul 29, 2026 | +6.5% | +6.5% | +5.4% |
| Apr 30, 2026 | -26.4% | -24.3% | -23.9% |
Sales grew every year from 2018 to 2025, to $5.6B. It made a profit in five of the eight years.
RSI 75.5, MACD below signal, above both averages. Not scored.
Officers and directors with a Form 4 in the last 12 months.
In ETFs: OPCH is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
“The Company competes in the large and highly fragmented home and alternative site infusion market for contracts with managed care organizations and other third-party payers to receive referrals from physicians, case managers and hospital discharge planners.”
OPCH scores 13 today, which Breakaway calls Above Average. It has 7 of 14 chart checks firing. Up 12% over three years while the S&P 500 rose 80%; up 12% in the past year. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
OPCH scores 13 today, which Breakaway calls Above Average (11 to 14). The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind OPCH's 13.
Expected to report Tue Feb 23, before the open, a date Breakaway expects from the company's usual timing; the company has not confirmed it. OPCH closed higher after 1 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.